Literature DB >> 20921818

Cardiac abnormalities in primary hyperoxaluria.

Farouk Mookadam1, Travis Smith, Panupong Jiamsripong, Sherif E Moustafa, Carla G Monico, John C Lieske, Dawn S Milliner.   

Abstract

BACKGROUND: In patients with primary hyperoxaluria (PH), oxalate overproduction can result in recurrent urolithiasis and nephrocalcinosis, which in some cases results in a progressive decline in renal function, oxalate retention, and systemic oxalosis involving bone, retina, arterial media, peripheral nerves, skin, and heart. Oxalosis involving the myocardium or conduction system can potentially lead to heart failure and fatal arrhythmias. METHODS AND
RESULTS: A retrospective review of our institution's database was conducted for all patients with a confirmed diagnosis of PH between 1/1948 and 1/2006 (n=103). Electrocardiogram (ECG) and echocardiography were used to identify cardiac abnormalities. Ninety-three patients fulfilled the inclusion criteria, 58% were male. Mean follow-up was 11.9 (median 8.8) years. In 38 patients who received an ECG or echocardiography, 31 were found to have any cardiac abnormalities. Cardiac findings correlated with decline in renal function.
CONCLUSIONS: Our data suggests that physicians caring for patients with PH should pay close attention to cardiac status, especially if renal function is impaired.

Entities:  

Mesh:

Year:  2010        PMID: 20921818      PMCID: PMC5929473          DOI: 10.1253/circj.cj-10-0107

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  40 in total

Review 1.  Twist and untwist mechanics of the left ventricle.

Authors:  Partho P Sengupta; Bijoy K Khandheria; Jagat Narula
Journal:  Heart Fail Clin       Date:  2008-07       Impact factor: 3.179

2.  Primary oxalosis with cardiac manifestations.

Authors:  K Hamaya; K Ohishi
Journal:  Acta Pathol Jpn       Date:  1980-05

3.  Primary oxalosis of the heart: a cause of heart block.

Authors:  D J Coltart; R E Hudson
Journal:  Br Heart J       Date:  1971-03

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Reversal of oxalosis cardiomyopathy after combined liver and kidney transplantation.

Authors:  Olivier Detry; Pierre Honoré; Arnaud DeRoover; Mounir Trimeche; Jean-Claude Demoulin; Marianne Beaujean; Martial Moonen; Jean-Pierre Godon; Jacques Boniver; Nicolas Jacquet; Michel Meurisse
Journal:  Transpl Int       Date:  2002-01-18       Impact factor: 3.782

6.  Primary oxalosis with myocardial involvement and heart block.

Authors:  A M Tonkin; H G Mond; T H Mathew; J G Sloman
Journal:  Med J Aust       Date:  1976-06-05       Impact factor: 7.738

7.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

8.  L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis.

Authors:  Tai Sakurabayashi; Shigeru Miyazaki; Yasuko Yuasa; Shinji Sakai; Masashi Suzuki; Sachio Takahashi; Yoshihei Hirasawa
Journal:  Circ J       Date:  2008-06       Impact factor: 2.993

9.  Pulmonary hypertension in chronic renal failure patients.

Authors:  Saeed Abdelwhab; Samah Elshinnawy
Journal:  Am J Nephrol       Date:  2008-07-17       Impact factor: 3.754

Review 10.  Heart failure with mitral valve regurgitation due to primary hyperoxaluria type 1: case report with review of the literature.

Authors:  Luc Van Driessche; Annemieke Dhondt; Johan De Sutter
Journal:  Acta Cardiol       Date:  2007-04       Impact factor: 1.718

View more
  17 in total

Review 1.  Recent advances in the identification and management of inherited hyperoxalurias.

Authors:  David J Sas; Peter C Harris; Dawn S Milliner
Journal:  Urolithiasis       Date:  2018-12-10       Impact factor: 3.436

2.  Hyperoxaluria and rapid development of renal failure following a combined liver and kidney transplantation: emphasis on sequential transplantation.

Authors:  Ahmed M Alkhunaizi; Nouriya A Al-Sannaa; Wasim F Raslan
Journal:  JIMD Rep       Date:  2011-09-06

3.  Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study.

Authors:  Ruth Lagies; Floris E A Udink Ten Cate; Markus Feldkötter; Bodo B Beck; Narayanswami Sreeram; Bernd Hoppe; Ulrike Herberg
Journal:  Pediatr Nephrol       Date:  2019-08-22       Impact factor: 3.714

Review 4.  Genetic Infiltrative Cardiomyopathies.

Authors:  Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

Review 5.  Genetic assessment in primary hyperoxaluria: why it matters.

Authors:  Giorgia Mandrile; Bodo Beck; Cecile Acquaviva; Gill Rumsby; Lisa Deesker; Sander Garrelfs; Asheeta Gupta; Justine Bacchetta; Jaap Groothoff
Journal:  Pediatr Nephrol       Date:  2022-06-13       Impact factor: 3.714

6.  ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.

Authors:  Gema Ariceta; Laure Collard; Saoussen Abroug; Shabbir H Moochhala; Edward Gould; Abir Boussetta; Mohamed Ben Hmida; Sudarsana De; Tracy E Hunley; Faical Jarraya; Gloria Fraga; Ana Banos; Elisabeth Lindner; Bastian Dehmel; Gesa Schalk
Journal:  Pediatr Nephrol       Date:  2022-05-12       Impact factor: 3.714

Review 7.  Update on oxalate crystal disease.

Authors:  Elizabeth C Lorenz; Clement J Michet; Dawn S Milliner; John C Lieske
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

Review 8.  Storage diseases with hypertrophic cardiomyopathy phenotype.

Authors:  Luis Ruiz-Guerrero; Roberto Barriales-Villa
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

9.  High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.

Authors:  Anja Pfau; Theresa Ermer; Steven G Coca; Maria Clarissa Tio; Bernd Genser; Martin Reichel; Fredric O Finkelstein; Winfried März; Christoph Wanner; Sushrut S Waikar; Kai-Uwe Eckardt; Peter S Aronson; Christiane Drechsler; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2021-07-19       Impact factor: 14.978

10.  Anaesthesia and intensive care for simultaneous liver-kidney transplantation: A single-centre experience with 12 recipients.

Authors:  Akila Rajakumar; Shiwalika Gupta; Selvakumar Malleeswaran; Joy Varghese; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  Indian J Anaesth       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.